Showing results (1-10 of 148) with videos related to
Sort By:
Pageof 15
Psychiatry Research|October 1, 1989
Dexamethasone suppression test in positive and negative schizophreniaC Altamura, G Guercetti, M PercudaniInternational Clinical Psychopharmacology|January 1, 1989
Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitryptilineA C Altamura, M Percudani, G Guercetti, et al.International Journal of Clinical Pharmacology Research|January 1, 1989
Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trialA C Altamura, F De Novellis, G Guercetti, et al.Acta Psychiatrica Scandinavica|August 1, 1986
Prophylactic treatment with mianserin, therapy adherence and plasma monitoring. A case reportA C Altamura, M Mauri, G GuercettiProgress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1986
Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levelsA C Altamura, M C Mauri, G GuercettiThe Journal of Clinical Psychiatry|August 1, 1993
The use of antidepressants for long-term treatment of recurrent depression: rationale, current methodologies, and future directionsA C Altamura, M PercudaniProgress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1987
Fluphenazine decanoate in acute and maintenance therapy of schizophreniaA C Altamura, M C Mauri, G Guercetti, et al.Clinical Pharmacokinetics|March 1, 1994
Clinical pharmacokinetics of fluoxetineA C Altamura, A R Moro, M PercudaniClinical Neuropharmacology|January 1, 1990
Alternative prophylactic treatments to lithium in bipolar disordersM C Mauri, M Percudani, M G Regazzetti, et al.Pharmacopsychiatry|November 1, 1989
Residual neuroleptic-induced parkinsonian symptoms in schizophrenia. A naturalistic study with orphenadrineA C Altamura, M C Mauri, F De Novellis, et al.Pageof 15